b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">31371924</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>06</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>25</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Electronic">1177-8881</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>13</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Drug design, development and therapy</Title>\n                <ISOAbbreviation>Drug Des Devel Ther</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>2305-2330</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.2147/DDDT.S204974</ELocationID>\n            <Abstract>\n                <AbstractText Label="Introduction" NlmCategory="UNASSIGNED">The efficacy of cyclosporine A (CsA) in the treatment of idiopathic membranous nephropathy (IMN) is unclear. This meta-analysis was conducted to assess the efficacy and the safety of CsA in the treatment of IMN in Asians.</AbstractText>\n                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">We searched the Pubmed, China Biomedical Database, CNKI, Wanfang Data, VIP, and EMBASE (November 30, 2018) systematically to identify the appropriate randomized controlled trials (RCTs) reporting the efficacy and the safety of CsA and glucocorticoid (GC) treatment vs other immunosuppressants and GC on patients with IMN in Asian populations.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The CsA treated group entered complete remission (CR) faster (3 months) than a cyclophosphamide (CTX) group. While the CsA group lower inefficacy rates and higher total remission (TR, CR, or partial remission) than the CTX group in the total treatment (3 months, 6 months, and 12 months), it had a higher relapse rate. As for the CsA group vs the tacrolimus (TAC) group, the TAC had a significant effect in increasing the CR and the TR, with decreased no remission. With the therapeutic regimens of CsA+GC vs CTX+GC, the CsA exhibited better efficacy in lowering the proteinuria levels only at 12 months, not at 3 months or 6 months. Severe events like leucopenia, hemorrhagic cystitis, and alopecia were observed in the CTX group. Gingival hyperplasia, hirsutism, and elevated blood pressure were reported only in the CsA group. Gastrointestinal syndrome, liver function lesion, happened more frequently in the CTX group, and elevated uric acid was more common in the CsA group.</AbstractText>\n                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">In brief, the CsA has better efficacy than the CTX group in the Asian population, with mild adverse effects but higher relapse rates in short-term treatment.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Lin</LastName>\n                    <ForeName>Shujun</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou 515041, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Li</LastName>\n                    <ForeName>Hong-Yan</ForeName>\n                    <Initials>HY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Nephrology, Huadu District People\'s Hospital of Guangzhou, Southern Medical University, Guangzhou 510800, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhou</LastName>\n                    <ForeName>Tianbiao</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou 515041, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lin</LastName>\n                    <ForeName>Wenshan</ForeName>\n                    <Initials>W</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Nephrology, The Second Affiliated Hospital of Shantou University Medical College, Shantou 515041, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D017418">Meta-Analysis</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>11</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>New Zealand</Country>\n            <MedlineTA>Drug Des Devel Ther</MedlineTA>\n            <NlmUniqueID>101475745</NlmUniqueID>\n            <ISSNLinking>1177-8881</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>83HN0GTJ6D</RegistryNumber>\n                <NameOfSubstance UI="D016572">Cyclosporine</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D044466" MajorTopicYN="Y">Asian Continental Ancestry Group</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016572" MajorTopicYN="N">Cyclosporine</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015433" MajorTopicYN="N">Glomerulonephritis, Membranous</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">cyclophosphamide</Keyword>\n            <Keyword MajorTopicYN="N">cyclosporine A</Keyword>\n            <Keyword MajorTopicYN="N">idiopathic membranous nephropathy</Keyword>\n            <Keyword MajorTopicYN="N">mycophenolate mofetil</Keyword>\n            <Keyword MajorTopicYN="N">tacrolimus</Keyword>\n        </KeywordList>\n        <CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>12</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>2</Month>\n                <Day>7</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31371924</ArticleId>\n            <ArticleId IdType="doi">10.2147/DDDT.S204974</ArticleId>\n            <ArticleId IdType="pii">204974</ArticleId>\n            <ArticleId IdType="pmc">PMC6628962</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Expert Opin Investig Drugs. 2000 May;9(5):1053-63</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11060727</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Semin Nephrol. 2003 Jul;23(4):362-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12923724</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Kidney Dis. 2004 Sep;44(3):562-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15332231</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Soc Nephrol. 2005 May;16(5):1188-94</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15800117</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann N Y Acad Sci. 2005 Jun;1051:551-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16126995</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Soc Nephrol. 2007 Jun;18(6):1899-904</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17494881</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Expert Opin Pharmacother. 2008 Jul;9(10):1695-704</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18570603</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Kidney Dis. 2008 Oct;52(4):691-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18805348</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19218475</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drugs. 2009 Jul 9;69(10):1303-17</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19583450</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Soc Nephrol. 2010 Apr;21(4):697-704</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20110379</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Soc Nephrol. 2012 Oct;23(10):1617-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22859855</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2012;7(9):e44330</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22957065</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2013 Mar 2;381(9868):706-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23312809</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Kidney Dis (Basel). 2015 Sep;1(2):126-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27536673</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Autoimmun Rev. 2017 Feb;16(2):136-145</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27988429</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Drugs. 2017 Feb;77(2):187-199</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28084563</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Soc Nephrol. 2017 Sep;28(9):2729-2737</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28487395</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2017 Sep 12;12(9):e0184398</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28898290</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Korean Med Sci. 2018 Feb 26;33(9):e74</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29441742</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'